Main > CARDIOLOGY (**) > DE. B. CHF>Treat.>sGC Stimulator>



DE. B. CHF>Treat.>sGC Stimulator>'s subsections
(*) EU CE Mark Date: 2021. 07.21.
(*) USA Approval Date: 2021. 01.20
>with reduced ejection fraction>
Company EU
Company USA
Generic Name: vericiguat
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 11
Patent>UpDate: 2021. 07.20
RTM
sGC: soluble guanylate cyclase

DE. B. CHF>Treat.>sGC Stimulator>'s products
This section has no products